PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Precision and Future Medicine10.23838/pfm.2017.0010820171152-57HER2, estrogen receptor-negative metastatic hidradenocarcinoma: identification of TP53 mutation in both primary and cell-free DNASiho Kim, Jinhyun Cho, Won Park, Sang-Hee Choi, Woongyang Park, Kee-Taek Jang, Jeeyun Leehttp://pfmjournal.org/journal/view.php?doi=10.23838/pfm.2017.00108, http://pfmjournal.org/upload/pdf/pfm-2017-00108.pdf, http://pfmjournal.org/upload/pdf/pfm-2017-00108.pdf
European Journal of Cancer10.1016/s0959-8049(02)80344-620023811S107-S108TP53 mutation and/or overexpression of the HER2 receptor are strong indicators of poor prognosis in both node-negative and node-positive early breast cancerJ Alsnerhttps://api.elsevier.com/content/article/PII:S0959-8049(02)80344-6?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959-8049(02)80344-6?httpAccept=text/plain
npj Breast Cancer10.1038/s41523-022-00384-3202281Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancerJung Hwan Ji, Soong June Bae, Kyungsoo Kim, Chihhao Chu, Kyung-A Lee, Yoonjung Kim, Jee Hung Kim, Joon Jeong, Sung Gwe Ahnhttps://www.nature.com/articles/s41523-022-00384-3.pdf, https://www.nature.com/articles/s41523-022-00384-3, https://www.nature.com/articles/s41523-022-00384-3.pdf
Український радіологічний та онкологічний журнал10.46879/ukroj.2.2022.50-61202230250-61Clinical significance of estrogen receptor gene polymorphisms in patients with metastatic luminal (Her2-negative) breast cancerT.Ye. Tarasenkohttps://ukroj.com/index.php/journal/article/download/155/88, https://ukroj.com/index.php/journal/article/download/155/88
Breast Cancer10.1007/s12282-018-0861-92018255605-613HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancerHitomi Sakai, Junji Tsurutani, Tsutomu Iwasa, Yoshifumi Komoike, Kazuko Sakai, Kazuto Nishio, Kazuhiko Nakagawahttp://link.springer.com/article/10.1007/s12282-018-0861-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12282-018-0861-9.pdf, http://link.springer.com/content/pdf/10.1007/s12282-018-0861-9.pdf
The Breast10.1016/s0960-9776(15)30096-5201524S50-S51PR84 FULVESTRANT COMBINED WITH CAPECITABINE MAY BE EFFECTIVE AND WELL TOLERATED FOR PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCERMaki Nakaihttps://api.elsevier.com/content/article/PII:S0960977615300965?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977615300965?httpAccept=text/plain
Breast Cancer Research and Treatment10.1007/s10549-017-4478-z20171663911-917Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institutionJunichiro Watanabe, T. Hayashi, Y. Tadokoro, S. Nishimura, K. Takahashihttp://link.springer.com/article/10.1007/s10549-017-4478-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10549-017-4478-z.pdf, http://link.springer.com/content/pdf/10.1007/s10549-017-4478-z.pdf
Cancer Treatment Reviews10.1016/j.ctrv.2017.12.002201863144-155Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancerGül A. Başaran, Chris Twelves, Véronique Diéras, Javier Cortés, Ahmad Awadahttps://api.elsevier.com/content/article/PII:S0305737217302049?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737217302049?httpAccept=text/plain
Diagnostic Cytopathology10.1002/dc.213892011395328-332Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinomaAhmed Shabaik, Grace Lin, Michael Peterson, Farnaz Hasteh, Ann Tipps, Brian Datnow, Noel Weidnerhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdc.21389, http://onlinelibrary.wiley.com/wol1/doi/10.1002/dc.21389/fullpdf
10.21203/rs.3.rs-1680356/v12022Adolescent Triple-negative Breast Cancer with Germline Mutation of both BRCA1 and TP53: A Case ReportDongmei Chen, Mengqi Yuan, Ying Zhang, Chenyang Zhang, Donggui Wanhttps://www.researchsquare.com/article/rs-1680356/v1, https://www.researchsquare.com/article/rs-1680356/v1.html